Anteris Technologies Ltd
ASX:AVR

Watchlist Manager
Anteris Technologies Ltd Logo
Anteris Technologies Ltd
ASX:AVR
Watchlist
Price: 7.7 AUD -1.16%
Market Cap: 317.2m AUD

Anteris Technologies Ltd
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Anteris Technologies Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Anteris Technologies Ltd
ASX:AVR
Total Other Income
-AU$62.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Total Other Income
-AU$1.1m
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Polynovo Ltd
ASX:PNV
Total Other Income
AU$1.5m
CAGR 3-Years
48%
CAGR 5-Years
580%
CAGR 10-Years
N/A
SDI Ltd
ASX:SDI
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Total Other Income
-$3.4m
CAGR 3-Years
3%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Anteris Technologies Ltd
Glance View

Market Cap
317.2m AUD
Industry
Health Care

Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. The company is headquartered in Toowong, Queensland. The company went IPO on 2004-03-24. The firm is engaged in delivering solutions that help healthcare professionals. The firm operates through two segments: operations and projects. Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. The company offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold, which is a tissue technology platform that demonstrates zero calcification. xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and unparalleled durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

AVR Intrinsic Value
Not Available

See Also

What is Anteris Technologies Ltd's Total Other Income?
Total Other Income
-62.1k AUD

Based on the financial report for Dec 31, 2023, Anteris Technologies Ltd's Total Other Income amounts to -62.1k AUD.

What is Anteris Technologies Ltd's Total Other Income growth rate?
Total Other Income CAGR 1Y
44%

Over the last year, the Total Other Income growth was 44%.

Back to Top